Search

Your search keyword '"Boston Scientific Corp. -- Product development"' showing total 141 results
Start Over Descriptor "Boston Scientific Corp. -- Product development" Topic clinical trials
141 results on '"Boston Scientific Corp. -- Product development"'

1. Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Patient compliance, Anticoagulants (Medicine), Atrial fibrillation -- Risk factors, Medical equipment and supplies industry -- Product development, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. Key findings from the study [...]

Published
2024

2. Boston Scientific WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Patient compliance, Anticoagulants (Medicine), Atrial fibrillation, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and CHICAGO, Nov. 16, [...]

Published
2024

3. ACURATE neo2tm Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Heart valve diseases, General interest, News, opinion and commentary
Abstract

MARLBOROUGH, Mass. and WASHINGTON: Boston Scientific Corporation has issued the following news release: Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE [...]

Published
2024

4. ACURATE neo2(TM) Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Aortic valve stenosis, Business, News, opinion and commentary
Abstract

MARLBOROUGH, Mass. and WASHINGTON, Oct. 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which evaluated [...]

Published
2024

5. BIDMC-LED TRIAL LEADS TO FDA APPROVAL OF CORONARY DRUG-COATED BALLOONS

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Light-emitting diodes -- Product development, Medical centers, Cardiology, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Drug approval, Clinical trials, Cardiac patients, Transluminal angioplasty, News, opinion and commentary, Beth Israel Deaconess Medical Center
Abstract

BOSTON, MA -- The following information was released by Beth Israel Deaconess Medical Center (BIDMC): First-of-its-kind Trial in US Shows Drug-coated Balloons are a Superior Treatment Option for Patients Undergoing [...]

Published
2024

6. Feinstein Institutes implants modular CRM system in patient to be enrolled in Boston Scientific MODULAR ATP clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Customer relationship management, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Clinical trials, Research institutes, Customer relationship management software, Customer relationship management, Pharmaceuticals and cosmetics industries
Abstract

Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm [...]

Published
2022

7. Boston Scientific initiates AVANT GUARD clinical trial to evaluate FARAPULSE Pulsed Field Ablation System

Subjects
Boston Scientific Corp. -- Product development, Atrial fibrillation, Anti-arrhythmia drugs -- Product development, Electric fields, Clinical trials, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line treatment for [...]

Published
2023

8. Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE(TM) Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation -- Drug therapy, Anti-arrhythmia drugs -- Product development, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Electric fields, Clinical trials, Business, News, opinion and commentary
Abstract

MARLBOROUGH, Mass., Dec. 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE(TM) Pulsed Field [...]

Published
2023

9. BIDMC-led trial leads to FDA approval of coronary drug-coated balloons

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Medical centers, Cardiology, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Drug approval, Clinical trials, Cardiac patients, Transluminal angioplasty, Business, Health, Health care industry, Beth Israel Deaconess Medical Center
Abstract

2024 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- BOSTON - In the largest randomized clinical trial and first [...]

Published
2024

10. Recent Findings in Peripheral Artery Disease Described by Researchers from Boston Scientific (Diversity In Clinical Trial Inclusion for Peripheral Artery Disease Lower Extremity Endovascular Interventions: a Systematic)

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiovascular diseases, Health
Abstract

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in Cardiovascular Diseases and Conditions - Peripheral Artery Disease. According to [...]

Published
2024

11. Boston Scientific announces results from PROTECTED TAVR clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL Cerebral Protection System, which is designed to capture and remove embolic debris stemming from transcatheter aortic [...]

Published
2022

12. Boston Scientific announces results from Ekosonic System clinical trial

Subjects
Boston Scientific Corp. -- Product development, Pulmonary embolism, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific announced positive results for the EkoSonic Endovascular System during a late-breaking clinical trial presentation at the Vascular InterVentional Advances, or VIVA, meeting in Las Vegas. Data from the [...]

Published
2021

13. Boston begins enrollment in HI-PEITHO trial for EkoSonic Endovascular System for treatment of acute, intermediate-high-risk pulmonary embolism

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers, Medical test kit industry -- Product development, Pulmonary embolism -- Care and treatment, Medical equipment and supplies industry -- Product development, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the [...]

Published
2021

14. Boston Scientific reports 'positive' results from PINNACLE FLX clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Boston Scientific announced positive 24-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure Device for patients with [...]

Published
2021

15. Feinstein Institutes, Northwell electrophysiologist successfully implant first modular cardiac rhythm management system in novel clinical trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Prosthesis -- Product development, Implants, Artificial -- Product development, Customer relationship management software -- Product development, Clinical trials, Research institutes, Customer relationship management software, Business, Business, international
Abstract

MANHASSET, N.Y. -- Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a [...]

Published
2022

16. SIO Announces ACCLAIM Clinical Trial with Ground Breaking Support from Industry Partners

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Metastasis, Medical equipment and supplies industry -- Product development, Liver, Clinical trials, Business, News, opinion and commentary
Abstract

WASHINGTON, Nov. 18, 2021 /PRNewswire/ -- The Society of Interventional Oncology (SIO) announces the launch of the society's first clinical trial, 'Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective [...]

Published
2021

17. Positive Late-breaking Clinical Trial Data for the EkoSonic Endovascular System Presented at VIVA21

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Pulmonary embolism, Medical equipment and supplies industry -- Product development, Clinical trials, Evidence-based medicine, General interest, News, opinion and commentary
Abstract

LAS VEGAS and MARLBOROUGH: Boston Scientific Corporation has issued the following news release: Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic Endovascular System (EKOS system) during a [...]

Published
2021

18. Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger Drug-Coated Balloon

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, General interest, News, opinion and commentary
Abstract

LAS VEGAS: Boston Scientific Corporation has issued the following news release: Today, Boston Scientific (NYSE: BSX) announced positive results for the Ranger Drug-Coated Balloon (DCB) during a late-breaking clinical trial [...]

Published
2021

19. Positive Late-breaking Clinical Trial Data for the EkoSonic(TM) Endovascular System Presented at VIVA21

Subjects
Boston Scientific Corp. -- Product development, Respiratory agents, Pulmonary embolism, Clinical trials, Evidence-based medicine, Business, News, opinion and commentary
Abstract

Analysis found no intracerebral hemorrhages, low major bleeding rates; registry represents largest data set in interventional treatment of pulmonary embolism LAS VEGAS and MARLBOROUGH, Mass., Oct. 5, 2021 /PRNewswire/ -- [...]

Published
2021

21. Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(TM) Endovascular System

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical centers, Medical test kit industry -- Product development, Respiratory agents, Pulmonary embolism -- Care and treatment, Anticoagulants (Medicine), Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Study is first to compare interventional therapy in combination with anticoagulation to anticoagulation alone for treatment of pulmonary embolism MARLBOROUGH, Mass., Aug. 4, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: [...]

Published
2021

22. Mon Health in clinical trial to help stop strokes

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation -- Prevention, Medical centers, Medical equipment industry -- Product development, Cardiac patients, Stroke -- Prevention, Fibrillation, Business, General interest, Business, regional
Abstract

Byline: Suzanne Elliott Feb. 18-- Feb. 18--WATCHMAN FLX designed to prevent movement of clots Mon Health Medical Center was tapped by Boston Scientific, a developer of a device that reduces [...]

Published
2020

23. Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation has issued the following press release: Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) - [...]

Published
2021

24. Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, General interest, News, opinion and commentary
Abstract

MARLBOROUGH: Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) - a type of radioembolization comprised of millions of microscopic glass beads [...]

Published
2021

25. Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, Business, international, Law
Abstract

Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) a type of radioembolization comprised of millions of microscopic glass beads [...]

Published
2021

26. Late-Breaking Clinical Trial Data for TheraSphere(TM) Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Liver cancer, Business, News, opinion and commentary
Abstract

Data presented at SIR 2021 confirm safety and dose-efficacy relationship MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of [...]

Published
2021

27. MidMichigan Medical Center-Midland enrolls first Michigan patient in advanced clinical trial

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation, Medical centers, Medical research, Anticoagulants, Business, international, Law
Abstract

MidMichigan Medical Center Midland recently enrolled the first Michigan patient in the OPTION clinical trial study. The medical center is one of only two locations in Michigan and one of [...]

Published
2020

28. PINNACLE FLX Study of the WATCHMAN FLX Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation, Medical equipment industry -- Product development, Medical research, Anticoagulants, Vitamins, Fibrillation, Business, international, Law
Abstract

Today, Boston Scientific (NYSE: BSX) announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure (LAAC) [...]

Published
2020

29. PINNACLE FLX Study of the WATCHMAN FLX Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation, Medical equipment industry -- Product development, Medical research, Anticoagulants, Vitamins, Fibrillation, General interest, News, opinion and commentary
Abstract

Marlborough: Boston Scientific has issued the following press release: Today, Boston Scientific (NYSE: BSX) announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of [...]

Published
2020

30. PINNACLE FLX Study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Anticoagulants (Medicine), Atrial fibrillation, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

Trial meets primary safety and efficacy endpoints with low complication rates, 100% effective closure with next-generation stroke risk reduction technology for patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., May 8, [...]

Published
2020

31. Late-Breaking Trial Data Highlight Continued Clinical Success Of Boston Scientific EMBLEM S-ICD System

Subjects
Boston Scientific Corp. -- Product development, Medical equipment industry -- Product development, Cardiac patients, Heart, Sudden cardiac death, Prostheses and implants, Death, Clinical trials, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO: Boston Scientific has issued the following press release: Boston Scientific (NYSE: BSX) today announced acute results from the UNTOUCHED study evaluating safety and efficacy of the EMBLEM Subcutaneous [...]

Published
2019

32. Late-breaking Clinical Trial Highlights Positive Safety and Efficacy Data for the LUMINIZE RF Balloon Catheter

Subjects
Boston Scientific Corp. -- Product development, Medical equipment industry -- Product development, Ablation (Surgery), Clinical trials, Atrial fibrillation, Medical research, Antiarrhythmia agents -- Product development, Cardiac patients, Cardiovascular agents, Fibrillation, Arrhythmia, Drugs, General interest, News, opinion and commentary
Abstract

Marlborough: Boston Scientific has issued the following press release: Boston Scientific Corporation (NYSE: BSX) announced data from the AF-FICIENT I study during a late-breaking clinical trial session today at EHRA [...]

Published
2019

33. Late-breaking Clinical Trial Highlights Positive Safety and Efficacy Data for the LUMINIZE(TM) RF Balloon Catheter

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Atrial fibrillation, Anti-arrhythmia drugs -- Product development, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Clinical trials, Physiological apparatus -- Product development, Cardiac patients, Business, News, opinion and commentary
Abstract

New data showcasing performance of recently acquired RF balloon-based, single-shot ablation technology LISBON, Portugal and MARLBOROUGH, Mass., March 17, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced data from [...]

Published
2019

34. Neuros Medical raises $20 million to fund clinical trial

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Chronic pain, Venture capital companies -- Product development, Medical equipment industry -- Product development, Business, Business, regional
Abstract

Byline: CHUCK SODER Neuros Medical has raised $20 million that should allow the nerve stimulation company to finish a clinical trial involving 130 patients who suffer from post-amputation pain. The [...]

Published
2017

35. Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA Mapping System

Subjects
Boston Scientific Corp. -- Product development, Clinical trials, Atrial fibrillation, Medical equipment industry -- Product development, Medical research, General interest, News, opinion and commentary
Abstract

BARCELONA, Spain : Boston Scientific Corporation has issued the following press release: Boston Scientific Corporation (NYSE: BSX) announced real-world data from the TRUE-HD study during a late-breaking clinical trial session [...]

Published
2018

36. Late-Breaking Clinical Trial Data Further Demonstrate Safety And Effectiveness Of Rhythmia Mapping System

Subjects
E*TRADE Financial Corp. -- Product development, Boston Scientific Corp. -- Product development, Clinical trials, Arrhythmia, Securities industry -- Product development, Medical equipment industry -- Product development, Securities industry, General interest, News, opinion and commentary
Abstract

New York City: E*TRADE Financial Corporation (ETFC) has issued the following press release: Boston Scientific Corp: * LATE-BREAKING CLINICAL TRIAL DATA FURTHER DEMONSTRATE SAFETY AND EFFECTIVENESS OF THE RHYTHMIA MAPPING [...]

Published
2018

37. Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA(TM) Mapping System

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Atrial fibrillation, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

BARCELONA, Spain and MARLBOROUGH, Mass., March 20, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at [...]

Published
2018

38. Boston Scientific supports cost of its new stent; A clinical trial has yet to show that its Synergy stent outperforms cheaper rivals, but device maker insists time will tell

Subjects
Boston Scientific Corp. -- Product development, Stents -- Product development, Clinical trials, Medical equipment industry -- Product development, General interest, News, opinion and commentary
Abstract

Byline: JOE CARLSON; STAFF WRITER Boston ScientificÆs ôblockbusterö Synergy stent for opening blocked arteries on the heart commands a higher price than its competitors, but so far the jury is [...]

Published
2016

39. Boston Sci reports completing ATLAS enrollment for Liberte

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stent (Surgery) -- Evaluation, Clinical trials, Health
Abstract

Boston Sci reports completing ATLAS enrollment for Liberte By HOLLAND JOHNSON Medical Device Daily Associate Managing Editor Boston Scientific (Natick, Massachusetts) reported that it has completed enrollment in its ATLAS [...]

Published
2005

40. Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 15

Subjects
Boston Scientific Corp. -- Product development, Stents -- Product development, Clinical trials, Medical equipment industry -- Product development, Business, News, opinion and commentary
Abstract

LAS VEGAS, Nov. 2, 2015 /PRNewswire/ -- http://vivaphysicians.org/ , a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, is excited to announce [...]

Published
2015

41. Boston Scientific Provides New Data on Clinical Trial Program of Lotus Valve System

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Valves -- Product development, Business
Abstract

Washington, DC, Sep 15, 2014 (MidnightTrader via COMTEX) -- Boston Scientific (BSX) said new data from a clinical trial program of the Lotus Valve System continue to demonstrate strong performance [...]

Published
2014

42. Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Cardiovascular agents -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Business, News, opinion and commentary
Abstract

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug. 30, 2014 /PRNewswire/ -- Boston Scientific has released the primary [...]

Published
2014

43. Boston Scientific: Lotus TAVI meets endpoint in clinical trial

Author

Saxena, Varun

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Science and technology
Abstract

Byline: Varun Saxena Only 1.1% of patients using the Lotus Valve System TAVI device had moderate paravalvular aortic regurgitation (also referred to as leaking) after 6 months, according to results [...]

Published
2014

44. Largest Randomized Clinical Trial Of Implantable Cardioverter Defibrillator Recipients Demonstrates Excellent Patient Outcomes With Or Without Defibrillation Testing

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Prosthesis -- Product development, Electric countershock, Implants, Artificial -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients -- Patient outcomes, Defibrillators -- Product development, Business, News, opinion and commentary
Abstract

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions NATICK, Mass., May 8, 2014 /PRNewswire/ -- A Boston [...]

Published
2014

45. Boston Scientific Begins Clinical Trial of ACUITY(TM) X4 LV Pacing Leads and RELIANCE(TM) 4-FRONT ICD Leads

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

NATICK, Mass., April 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY(TM) X4 left-ventricular (LV) pacing [...]

Published
2014

46. OrbusNeich starts up a U.S.-Japan trial of its dual-therapy stent

Author

Moore, Galen

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Science and technology
Abstract

Byline: Galen Moore http://www.fiercemedicaldevices.com/tags/orbusneich has enrolled its first patient in a two-country proof-of-concept study for its innovative dual-therapy stent. The Hong Kong medical device maker announced the start of clinical [...]

Published
2014

47. Boston Scientific begins clinical trial of Innova peripheral vascular drug-eluting stent system

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, Chemicals, plastics and rubber industries
Abstract

Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston [...]

Published
2013

48. Boston Scientific reports favourable clinical trial results assessing the OffRoad re-entry catheter system

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, Chemicals, plastics and rubber industries
Abstract

The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the legs. These blockages, called [...]

Published
2013

49. Boston Scientific Reports Favorable Six-Month Results From Lotus(TM) Valve System Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business, News, opinion and commentary
Abstract

REPRISE II Data Honored as Best Abstract 2013 at PCR London Valves Course NATICK, Massachusetts, September 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported favorable six-month results from [...]

Published
2013

50. Boston Scientific Reports Results from Lotus Clinical Trial, Settles Patent Litigation with OrbusNeich

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Business
Abstract

Boston, Sep 17, 2013 (MidnightTrader via COMTEX) -- Boston Scientific Corporation (BSX) reported 'favorable' 6-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results